Literature DB >> 863201

Effect of cholecystokinin-octapeptide on lower esophageal sphincter.

J Behar, P Biancani.   

Abstract

The effect of cholecystokinin-octapeptide (CCK-OP) on the lower esophageal sphincter (LES) was studied in 50 cats in vivo. CCK-OP caused a dose-dependent fall in LES pressures in all but 4 animals. Maximal sphincter relaxation was obtained with 200 to 400 ng of CCK-OP per kg of body weight. Atropine sulfate and/or hexamethonium, or adrenergic blocking agents (phentolamine or propranolol), in doses that completely inhibit the action of maximal doses of their respective agonists, failed to block the CCK-OP effect. Tetrodotoxin, however, in doses that denervates the LES, antagonized the CCK-OP-induced sphincter relaxation. In these tetrodotoxin-treated animals, CCK-OP produced LES contraction similar to that observed after pentagastrin. These results suggest that CCK-OP stimulates the postganglionic nonadrenergic, noncholinergic inhibitory neurons responsible for sphincter relaxation. CCK-OP also stimulates the circular muscle by direct action causing LES contraction. The latter becomes apparent when the innervation of the LES is abolished by tetrodoxtin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 863201

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Electrophysiological evidence for distinct vagal pathways mediating CCK-evoked motor effects in the proximal versus distal stomach.

Authors:  Shiho Okano-Matsumoto; James A McRoberts; Yvette Taché; David W Adelson
Journal:  J Physiol       Date:  2010-11-15       Impact factor: 5.182

Review 2.  What's new in the esophagus.

Authors:  J Dent
Journal:  Dig Dis Sci       Date:  1981-02       Impact factor: 3.199

3.  Pharmacological constriction of the lower oesophageal sphincter: a simple method of arresting variceal haemorrhage.

Authors:  S W Hosking; W Doss; H el-Zeiny; P Robinson; M S Barsoum; A G Johnson
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

4.  Motility Patterns Following Esophageal Pharmacologic Provocation With Amyl Nitrite or Cholecystokinin During High-Resolution Manometry Distinguish Idiopathic vs Opioid-Induced Type 3 Achalasia.

Authors:  Arash Babaei; Sadaf Shad; Benson T Massey
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-13       Impact factor: 11.382

Review 5.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

6.  Amyloidosis mimics achalasia's effect on lower esophageal sphincter.

Authors:  J R Lefkowitz; D L Brand; M D Schuffler; W R Brugge
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

7.  Beneficial effect of indomethacin on acid-induced esophagitis in cats.

Authors:  G L Eastwood; B D Beck; D O Castell; F C Brown; J R Fletcher
Journal:  Dig Dis Sci       Date:  1981-07       Impact factor: 3.199

8.  Cholecystokinin induces esophageal longitudinal muscle contraction and transient lower esophageal sphincter relaxation in healthy humans.

Authors:  Arash Babaei; Ravinder Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-14       Impact factor: 4.052

9.  Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action.

Authors:  J Behar; P Biancani
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

Review 10.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.